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Michael P. Scho¨n1 and Steffen Emmert1
Only 16 XPG-defective patients with 20 different mutations have been described. The current hypothesis is that
missense mutations impair repair (xeroderma pigmentosum (XP) symptoms), whereas truncating mutations
impair both repair and transcription (XP and Cockayne syndrome (CS) symptoms). We identified three cell lines
of XPG-defective patients (XP40GO, XP72MA, and XP165MA). Patients’ fibroblasts showed a reduced post-UVC
cell survival. The reduced repair capability, assessed by host cell reactivation, could be complemented by XPG
cDNA. XPG mRNA expression of XP165MA, XP72MA, and XP40GO was 83%, 97%, and 82.5%, respectively,
compared with normal fibroblasts. XP165MA was homozygous for a p.G805R mutation; XP72MA and XP40GO
were both compound heterozygous (p.W814S and p.E727X, and p.L778P and p.Q150X, respectively). Allele-specific
complementation analysis of these five mutations revealed that p.L778P and p.W814S retained considerable
residual repair activity. In line with the severe XP/CS phenotypes of XP72MA and XP165MA, even the missense
mutations failed to interact with the transcription factor IIH subunits XPD and to some extent cdk7 in
coimmunoprecipitation assays. Immunofluorescence techniques revealed that the mutations destabilized early
recruitment of XP proteins to localized photodamage and delayed their redistribution in vivo. Thus, we identified
three XPGmissense mutations in the I-region of XPG that impaired repair and transcription and resulted in severe
XP/CS.
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INTRODUCTION
Xeroderma pigmentosum (XP) is caused by a defect in the
nucleotide excision repair (NER) pathway. XP is clinically
characterized by increased sun sensitivity and freckling within
the sun-exposed skin. The skin cancer risk is increasedB1000
fold. XP patients can also exhibit progressive neurological
degeneration with features of premature aging (Kraemer et al.,
1987). The incidence for XP in Western Europe is estimated
at 2.3 per million (Kleijer et al., 2008). XP patients can be
assigned to seven complementation groups XPA to XPG
depending on the mutated gene (Emmert et al., 2001). In
addition, an XP variant form (OMIM: 278750) is caused by
mutations in the gene coding for DNA polymerase eta involved
in translesion synthesis (Masutani et al., 1999).
The human XPG gene (OMIM: 278780) had been mapped
to chromosome 13q32.3-q33.1 (Emmert et al., 2001). XPG
consists of 1186 amino acids and belongs to the FEN-1 family
of structure-specific endonucleases characterized by two
highly conserved nuclease domains called N-region and
I-region. These regions contain a number of highly
conserved acidic residues that are required for the nuclease
function (Constantinou et al., 1999; Emmert et al., 2001). The
domain between N-region and I-region, ‘‘spacer region’’ or
‘‘R-Region’’, spans about 600 amino acids, mediates
recruitment to NER complexes, and determines substrate
specificity (Dunand-Sauthier et al., 2005) (Figure 5a).
In NER, the main function of XPG is the 30 incision of the
damage-containing DNA strand. Further, XPG, independent
from its endonuclease activity, is required for the 50 incision
by XPF (OMIM: 278760) (Staresincic et al., 2009). Another
important structural role of XPG is required for transcription by
stabilizing the architecture of the transcription factor IIH
(TFIIH) (Ito et al., 2007).
TFIIH consists of 10 proteins and can be divided into two
complexes: The core complex is composed of the six proteins
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XPB (OMIM: 610651), p62, p52, p44, p32, and p8 trichothio-
dystrophy. The cdk-activating kinase (CAK) complex contains
cdk7, cyclin H, and MAT1. Both complexes are bridged by
XPD (OMIM: 278730), which interacts with MAT1 (CAK) and
p44 (core). Interactions of the TFIIH proteins XPD, XPB, p62,
p44, and cdk7 with XPG have been shown in vivo and in vitro
(Iyer et al., 1996; Thorel et al., 2004; Dunand-Sauthier et al.,
2005; Ito et al., 2007).
TFIIH has a dual role: transcription (core complex and CAK)
and repair (core complex only). In transcription initiation, the
helicase subunit XPB is involved in promoter opening, and the
CAK protein cdk7 phosphorylates the C-terminal domain of
RNA polymerase II required for promoter escape (Dubaele
et al., 2003). Furthermore, cdk7 phosphorylates different
nuclear receptors (Le et al., 2010), which, once activated, in
turn transactivate transcription of certain genes (Ito et al.,
2007). The helicase function of XPD and the ATPase activity
of XPB are required for NER (Coin et al., 2007), whereas the
activity of CAK is dispensable for this process (Arab et al.,
2010).
Consequently, XPG mutations have been identified, result-
ing either in an XP phenotype (repair defect) or in a combined
XP/Cockayne syndrome (CS) phenotype (repair and transcrip-
tional defects) (Table 1) (Rapin et al., 2000). Patients suffering
from XP/CS exhibit XP symptoms together with classical CS
symptoms (OMIM: 216400, 133540) including developmental
retardation, dwarfism, and severe neurological abnormalities
(Rapin et al., 2000; Emmert et al., 2002).
Within our phenotype–genotype association studies of Ger-
man NER-defective patients, we identified three human
fibroblasts as XPG defective and five XPG mutations, and
showed that truncating and missense mutations impair repair
and XPG–TFIIH interaction, resulting in additional transcrip-
tional defects in line with the early-onset severe XP/CS
complex phenotype of the patients.
RESULTS
Clinical symptoms
Only 16 XPG-deficient patients and 20 different XPG muta-
tions have been described. We identified and characterized
three previously unreported cell lines of XPG-deficient
patients, XP72MA, XP165MA, and XP40GO. Patients
XP72MA and XP165MA were reported as being sun-sensitive
since birth and developed freckling within sun-exposed skin as
toddlers. Both were diagnosed as severe early-onset XP/CS
complex phenotypes. XP72MA developed no skin cancer up
to the age of 7 years but exhibited microcephaly, ataxia, and
neurological impairment. XP165MA exhibited dwarfism,
microcephaly, muscular hypotension, ataxia, reduced muscle
proprioceptive reflexes and neurological impairment. This
patient died at the age of 2 years from meningitis. Only
fibroblast cells but no further clinical data were available from
XP40GO.
Reduced post-UV cell survival
We tested fibroblasts of all patients with respect to their UVC
survival with media containing 1 mM caffeine (data not shown)
and without caffeine at a density of 5,000 and 7,500 cells per
well, respectively. The cells of the patients showed a markedly
reduced post-UV cell survival compared with wild-type
fibroblasts (Figure 1a).
Diminished NER capability and XP complementation group G
assignment
Host cell reactivation (HCR) using an UV-treated luciferase
reporter plasmid revealed reduced NER capability of all three
patients’ fibroblasts compared with wild-type fibroblasts
(Figure 1b). In order to assign the fibroblasts to the XP
complementation group G, cotransfection was performed with
plasmids expressing wild-type XP cDNA (XPA–XPG) along
with the reporter gene plasmid. Cotransfection of XPG cDNA
resulted in enhanced reporter gene activities. Cotransfection of
the other XP gene expression plasmids had no effect on
luciferase expression (data not shown).
Normal XPG mRNA expression
We measured the XPG mRNA expression of the patients’
fibroblasts using quantitative real-time reverse-transcriptase–
PCR normalized to both housekeeping genes b-actin and
GAPDH. The mean mRNA expression of nine wild-type
fibroblasts was set to 100%. XP72MA showed an mRNA
expression of 97%, XP40GO of 82.6%, and XP165MA of 83%
compared with normal, indicating absence of nonsense-
mediated message decay (Supplementary Figure S1 online).
Previously unreported XPG mutations
For XPG mutation detection, genomic DNA from primary
fibroblasts was sequenced and analyzed following the nomen-
clature of GenBank accession no. NM_000123.2. Patients
XP40GO and XP72MA were both compound heterozygous.
In XP40GO, a C to T transition at nucleotide position
891 leads to a change of glutamine at position 150 to a
premature stop codon in exon 4. On the other allele, a T to C
transition at position 2776 resulted in an amino-acid change
from leucine to proline at position 778 in exon 11. In
XP72MA, a G to T transversion at nucleotide position 2622
changed glutaminic acid into a stop codon at position 727 in
exon 9. On the other allele, tryptophan was changed to
serine at position 814 in exon 11 because of a G to C
transversion at position 2884. The patient XP165MA was
homozygous for a missense mutation in exon 11. A G to A
transition at nucleotide position 2856 changed glycine 805
to arginine in exon 11 (Table 1, Figure 5a, Supplementary
Figure S2 online).
Reduced repair activity of the mutated XPG alleles
To test the complementation ability of the mutated XPG
alleles, we constructed allele-specific expression vectors of
XPGQ150X, XPGE727X, XPGG805R, XPGL778P, and XPGW814S
and applied HCR. None of the mutated alleles could comple-
ment the NER capability comparable to wild-type pXPG.
A considerable residual repair activity was retained with
pXPGL778P and pXPGW814S, whereas repair activity was
greatly reduced with pXPGG805R and the two nonsense
mutations pXPGQ150X and pXPGE727X (Figure 2).
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All five XPG mutations impair interaction with TFIIH subunits
To test how the XPG mutations affect the interaction of XPG
with TFIIH, we constructed C-terminal mycHis-tagged XPG
allele–specific expression vectors. HEK932A cells were trans-
fected with plasmids expressing either XPGwtmycHis or
XPGmutmycHis. Immunoprecipitation probes (anti-myc) were
subjected to immunoblot analysis against XPD and cdk7. Both
proteins XPD and cdk7 were coimmunoprecipitated with
XPGwtmycHis under physiological conditions of 150 mM
NaCl. We found in three independent experiments repeatedly
that coimmunoprecipitation of XPD and cdk7 protein was not
observed or diminished with all five XPGmutmycHis constructs
including the three missense mutations (Figure 3).
No recruitment of XPG protein to sites of local DNA damage in
XPG-deficient cells
To assess how the XPG mutations affect the assembly of the
NER proteins, we performed time-course experiments for
protein recruitment to DNA photodamage, as well as
release from photodamage 6 minutes, 15 minutes, 30 minutes,
Table 1. Summary of all known XPG mutations
Protein Nucleotide Exon Phenotype Patient References
p.E11X c.474G4T 1 XP/CS severe, 6 yearsw XP20BE het. Moriwaki et al., 1996;
Okinaka et al., 1997
p.Q16X c.489C4T 1 XP/CS severe XP82DC het. Emmert et al., 2002
p.L65P c.637T4C 2 Mild XP XP3HM hom. Moriwaki et al., 2012
p.P72H c.658C4A 2 XP/CS severe XPCS4RO het. Zafeiriou et al., 2001
p.Q136X c.849C4T 4 XP XP65BE het. Emmert et al., 2002
p.R138X c.855C4T 4 XP/CS severe, 6 yearsw XP20BE het. Moriwaki et al., 1996;
Okinaka et al., 1997
p.Q150X c. 891 C4T 4 — XP40GO het. This study
p.Q176X c.969C4T 5/6 XP/CS severe XPCS4RO het. Zafeiriou et al., 2001
p.E225SfsX19 alternative
splicing p.E225-Q231del
Hom. deletion of last nucleotide of
splice acceptor site intron 6
7 XP/CS, late onset XPCS1BD het. Thorel et al., 2004
p.R263X c.1230C4T 7 XP/CS severe, 20 monthsw XPCS2LV het. Nouspikel et al., 1997
p.L308SfsX12 c.1364_1365delTC 7 XP/CS severe XP96TA hom. Emmert et al., 2002
p.R372TfsX6 c.1557_1560delAGGA 8 XP/CS severe, late onset XP2BI het. Lalle et al., 2002
p.K498LfsX25 c.1937delA 8 XP/CS severe, late onset XP3BR.het Lalle et al., 2002
p.S659VfsX1 c.2418delA 9 XP/CS severe, 6.5 yearsw, XP/
CS severe, 20 monthsw
XPCS1LV
hom.
XPCS2LV het.
Nouspikel et al., 1997
p.E727X c. 2622 G4T 9 XP/CS severe XP72MA het. This study
p.L778P c. 2776 T4C 11 — XP40GO het. This study
p.A792V c.2818C4T 11 XP mild XP125LO het.
XP124LO het.
Nouspikel and Clarkson,
1994; Norris et al., 1987
p.G805R c. 2856 G4A 11 XP/CS severe, 2 yearsw XP165MA
hom.
This study
p.W814S c. 2884 G4C 11 XP/CS severe XP72MA het. This study
p.L858P c.3015C4T 12 XP/CS severe, late onset XP2BI het. Lalle et al., 2002
p.A874T c.3063G4A 12 XP XP65BE het. Emmert et al., 2002
p.V869GfsX11 c.3049_3050delTG 12 XP/CS severe XP82DC het. Emmert et al., 2002
p.K917NfsX65 alternative
splicing K917fs962-fsX1186
c.3194delA 13 XP/CS severe, late onset XP3BR het. Lalle et al., 2002
p.G926AfsX56 c.3218delT 13 XP/CS severe, 7 monthsw 94RD27/
XPCS1RO
hom.
Nouspikel et al., 1997
p.E960X c.3321G4T 13 XP mild XP125LO het.
XP124LO het.
Nouspikel and Clarkson,
1994; Norris et al., 1987
Not determined Not determined XP mild XP31KO Ichihashi et al., 1985
Not determined Not determined XP mild XP52HM Yoneda et al., 2007
Abbreviations: CS, Cockayne syndrome; het., heterozygous; hom., homozygous; XP, xeroderma pigmentosum.
Mutations are listed in order of their appearance on the gene from 50 to 30 (based on GenBank accession no. NM_000123.2).
wAge at death.
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3 hours, 6 hours, and 24 hours after UV irradiation in our three
XPG-deficient cells compared with wild-type and XP3BR
XPG-deficient control fibroblasts using immunofluorescence
(Supplementary Figure S3 online). An XPG fluorescence
staining in wild-type cells revealed rapid recruitment and
redistribution of XPG protein to and from photodamage
(Figure 4e). In contrast, no positive XPG staining in cell nuclei
was observed in the fibroblasts of all three patients and the
XPG-deficient control at any time point after UV irradiation.
As the applied XPG antibody 8H7 maps to the C-terminal
region of XPG, the truncated proteins XPGQ150X in XP40GO
and XPGE727X in XP72MA, cannot, most likely, be recognized.
Early recruitment of other XP proteins is selectively delayed in
XPG-deficient cells
Immediately (6 minutes) after UV irradiation, all fibroblasts
(wild-type and XPG-deficient) were stained positive for cyclo-
butane pyrimidine dimers and pryrimidine-6,4-pyrimidone
photoproducts as expected. We found that XPA (OMIM:
278700) was equally rapidly recruited in wild-type, as well
as in all XPG-deficient fibroblasts XP40GO, XP165MA,
XP72MA, and XP3BR (50%, 46%, 36%, and 38%, respec-
tively) (Figure 4a). There was a markedly reduced and delayed
XPB recruitment in XP72MA (1%) (Figure 4b). In XP40GO and
XP72MA cells, early XPC (OMIM: 278720) recruitment was
clearly delayed (7 and 4%) (Figure 4c). ERCC1 (complexed
with XPF; OMIM: 126380) protein recruitment was delayed in
all three XPG-deficient cells compared with wild type and
XP3BR (Figure 4d).
No redistribution of other XP proteins in all XPG-deficient cells
Thirty minutes after UV irradiation, the XPG-deficient cells
reached their maximum of XP protein recruitment to photo-
damage (range: 39–60%). All XP proteins tested (XPC, XPB,
XPA, and ERCC1) were recruited to sites of local photo-
damage. At this time point, wild-type cells already released
nearly all XP proteins from DNA lesions (range: 2–9%,
Figure 4). After 24 hours, redistribution of XP proteins also
started in XPG-deficient cells; however, a considerable
amount of XP proteins persisted in the cells of all patients
and XP3BR control cells at sites of local photodamage (range:
13–49%). This paralleled a defective DNA photoproduct
removal in all XPG-deficient cells for 6,4PPs, as well as for
CPD (Figure 4f and g). Nevertheless, all XPG-deficient cells
could remove 50–70% of their 6,4PP within 24 hours but no
CPD (Figure 4g).
DISCUSSION
XPG mutations
To date, only 16 patients have been assigned to the com-
plementation group G. Six of these patients developed
classical XP symptoms. The other 10 patients exhibited the
XP/CS complex phenotype (Table 1). Our patients’ phenotypes
are in good agreement with previous clinical reports of XP/CS
complex patients (Moriwaki et al., 1996; Emmert et al., 2002).
So far, only 20 XPG mutations have been reported (Table 1).
In general, the presence of one missense mutation retaining
some functional XPG activity confers milder XP symptoms
(Emmert et al., 2002). For example, the p.A792V missense
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mutation is also located in the I-region but resulted just in a
mild XP phenotype without any neurological abnormalities in
patients with XP124LO and XP125LO (Nouspikel and
Clarkson, 1994). Two missense mutations have already been
described that do not fit into this hypothesis. The mutation
p.P72H is located in the N-region, resulted in a severe early-
onset XP/CS complex phenotype in XPCS4RO (Zafeiriou et al.,
2001), and was predicted to greatly destabilize the XPG
protein (Thorel et al., 2004). The mutation p.L858P
described in XP2BI is located in the same I-region as our
missense mutations, but it resulted in a mild late-onset XP/CS
phenotype probably because of some retained transcriptional
activity (Lalle et al., 2002). On the basis of the clinical
descriptions and the immunoprecipitation results (Figure 3),
our missense mutations in the I-region may more profoundly
impair the transcriptional role of XPG compared with
p.L858P.
Highly conserved amino-acid residues in the I-region and
the N-region are necessary for endonuclease proficiency of
XPG (Hosfield et al., 1998; Constantinou et al., 1999). An
alignment of the I-region (Figure 5b) revealed that the mutated
amino-acid residues L778, G805, and W814 are highly
conserved in humans, mice, and chickens. L778 is also highly
conserved through different members of the FEN-1 nuclease
family (Constantinou et al., 1999). W814 is adjacent to the
highly conserved amino-acid residue D812, which is crucial
for XPG cleavage activity (Constantinou et al., 1999). This is in
accordance with our results and can readily explain the
diminished repair capability of the patients’ fibroblasts.
Mutations impair interaction with TFIIH
That the truncated XPG proteins XPGQ150XmycHis (XP40GO)
and XPGE727XmycHis (XP72MA) showed no interaction with
XPD or with cdk7 is in line with previous reports (Ito et al.,
2007; Arab et al., 2010). Our three missense mutations were
all located within the I-region of XPG (747–928), which was
shown to interact with XPD. Two XPG–XPD-binding regions
were identified in vitro: XPG1–377 and XPG747–928. In addition,
single amino-acid residues in XPG are also crucial for other
XPG-protein interactions (Iyer et al., 1996). For example,
Arg992 is crucial for PCNA protein binding (Gary et al.,
1997). This supports our findings that missense mutations
impair XPG-protein interactions in general and that the single
amino-acid residues L778, G805, and W814 in XPG
are crucial for XPG–XPD interaction in particular. Therefore,
the severe early-onset XP/CS complex phenotype of our
patients with XP165MA and XP72MA can be explained by
impaired XPG–XPD, and to a lesser extent XPG–cdk7, inter-
actions due to the truncating and the three XPG missense
mutations. Ito et al. (2007) suggested that XPG and XPD
cooperatively mediate the anchoring of CAK to core TFIIH.
Core TFIIH is involved in NER, whereas CAK is dispensable
(Arab et al., 2010). However, CAK activity as part of TFIIH is
involved in general transcription (Ito et al., 2007; Scharer,
2008; Arab et al., 2010; Le et al., 2010). Abnormalities in the
transcriptional process in addition to defective repair cause CS
features in XP-mutated patients (Ito et al., 2007; Arab et al.,
2010). On the basis of our findings and the proposed
functional consequences, we can reasonably assume
that XP40GO also suffered from a severe XP/CS complex
phenotype.
Mutation-specific effects on repair factor assembly
In vitro and in vivo investigations suggest a sequential
assembly of the NER factors (Volker et al., 2001; Riedl
et al., 2003). That XPG was not recruited to local
photodamage indicates that all five mutated XPG proteins
do not properly interact with other NER proteins. Oh et al.
(2007) also described an impaired recruitment of XPG in XPG-
deficient cells. We also found recruitment of XPC, XPB, XPA,
and ERCC1 (complexed with XPF) proteins to local
photodamage in all XPG-deficient cells at 30 minutes after
UV irradiation in line with previous reports on XPG-deficient
cells with other mutations (Thorel et al., 2004; Oh et al., 2007;
Arab et al., 2010). At a very early time point (6 minutes), XPA
was also normally fast recruited, indicating that XPG is
dispensable for XPA recruitment (Oh et al., 2007). However,
the early fast recruitment of XPB and XPC may depend on
specific XPG mutations. We found a delayed early recruitment
of XPC in XP72MA and XP40GO and of XPB in XP72MA. This
might reflect that the strong functional interaction between
XPC and TFIIH (Araujo et al., 2001) is also affected by the
a myc IP
a myc
a XPD
a myc
a myc
a cdk7
a myc
100% 3% 2% 11% 2% 0%
XP
G wt
m
ycH
is
XP
G wt
m
ycH
is
XP
G wt
m
ycH
is
XP
G wt
m
ycH
is
XP
G wt
m
ycH
is
XP
G wt
m
ycH
is
XP
G G8
05
R
m
ycH
is
XP
G G8
05
R
m
ycH
is
XP
G L7
78
P
m
ycH
is
XP
G W
81
4s
m
ycH
is
XP
G E7
27
xm
ycH
is
XP
G q1
50
xm
ycH
is
XP
G L7
78
P
m
ycH
is
XP
G W
81
4S
m
ycH
is
XP
G E7
27
X
m
ycH
is
XP
G q1
50
X
m
ycH
is
a myc IP
100% 39% 77% 78% 39% 27%
Figure 3. XPG mutations impair interaction with TFIIH subunits XPD and cdk7. Wild-type XPGwtmycHis and XPGmutmycHis constructs were expressed in
HEK293A cells. Whole-cell extracts were used for immunoprecipitation with anti-myc antibody, and purified complexes were analyzed by immunoblotting with
the antibodies indicated. (a) No interaction with XPD was observed with all five XPGmutmycHis proteins in contrast to XPGwtmycHis. (b) No or reduced amounts of
cdk7 were coimmunoprecipitated with all five XPGmutmycHis proteins. The numbers indicate the ratio of band intensities for XPD and cdk7 obtained with each
mutated XPG construct relative to those obtained with the wild-type XPG construct (in %). Identical results were found in three independent experiments.
A Scha¨fer et al.
Five XPG Mutations
www.jidonline.org 1845
destabilization of TFIIH because of impaired interactions with
XPG (Ito et al., 2007; Arab et al., 2010). ERCC1–XPF
recruitment depends on XPG (Riedl et al., 2003). In line
with that, we observed a delayed early recruitment of ERCCI
in all three XPG-deficient cells (Figure 4). In the XP3BR
controls, early XP recruitment was normal, which may be
explained by a normal-length XPG splice variant in this cell
line (Lalle et al., 2002).
Redistribution of XP proteins results from the proceeding
repair of DNA photoproducts (Dunand-Sauthier et al., 2005;
Oh et al., 2007). Defective NER was reflected in all of our
XPG-deficient cells by persistence of XPA, XPB, XPC, and
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Figure 4. Selectively delayed early recruitment and impaired redistribution of xeroderma pigmentosum (XP) proteins in XPG-deficient fibroblasts. The
XPG-deficient cell line XP3BR was used as a control in addition to wild-type (WT) cells, because the cells harbor compound heterozygous deletions of one
nucleotide each (c.1937delA and c.3194delA); however, because of a minor splice variant, this cell still retains an almost full-length XP protein of 1,185, instead
of 1,186 amino acids (p.K917fs962-fsX1186). The time course of XP protein recruitment and redistribution after local UV irradiation was assessed with
immunofluorescence. Patients’ and wild-type fibroblasts were irradiated with 100 J m2 and incubated for the different intervals (0.1 hours, 0.5 hours, 3 hours,
6 hours, and 24 hours). Cells were fixed, permeabilized, and stained with antibodies against either one of the XP proteins (a) XPA, (b) XPB, (c) XPC, (d) ERCC1,
(e) XPG, or one of the UV lesions (f) CPD and (g) 6,4PP. A minimum of 100 nuclei were assessed at each time point to calculate the percentage of positively
stained nuclei. Data are presented as mean±SD.
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ERCC1 proteins at local photodamage even after 24 hours
(Figure 4). The least persistence was observed in XP3BR,
again, probably because of a normal-length XPG splice
variant. This is in agreement with observations from Arab
et al. (2010) and Oh et al. (2007) for cells from other XPG/CS
patients, and this has also been demonstrated for cells from
XPA, XPB, and XPC patients (Riedl et al., 2003; Oh et al.,
2007), as well as from XPD patients with and without
neurological symptoms (Boyle et al., 2008). This indicates
that the impaired redistribution of XP proteins reflects
impaired repair related to a XP phenotype and not to XP/CS
complex or XP plus neurological symptoms phenotypes. That
there was removal of 6-4PP over 24 hours in all cells
(Figure 4g) is in line with the residual repair activity of the
cells assessed by HCR (Figure 1b), as well as by testing each
mutated allele (Figure 2), and in good agreement with
previous reports (Emmert et al., 2002).
MATERIALS AND METHODS
Cells and cell-culture conditions
XP40GO (XP30MA), XP72MA, and XP165MA XPG-deficient primary
human fibroblasts and clinical data for XP72MA and XP165MA were
collected at the Department of Dermatology in Mannheim. XP3BR
fibroblasts were obtained from the Coriell Institute, Camden, NJ.
Wild-type primary fibroblasts (wt1GO-wt9GO) were established in
Go¨ttingen. HEK293A cells were purchased from Invitrogen (Karls-
ruhe, Germany). All cells were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 2% glutamine and
10% fetal bovine serum from Biochrom (Berlin, Germany). All studies
were conducted according to the Declaration of Helsinki principles.
The studies were performed in accordance with protocols approved
by the University of Go¨ttingen Institutional Review Board.
Post-UV cell survival
The post-UV cell survival was assessed as described (Thoms et al.,
2011). The mean absorption value of the nonirradiated cells was
set to 100% survival to calculate the relative post-UV survival of
the irradiated cells. At least two independent experiments were
performed in quadruplicate.
Plasmid HCR and complementation group assignment
Plasmid HCR and complementation group assignment were per-
formed as described previously (Emmert et al., 2002, 2006). The
plasmids were a generous gift from M. Hedayati and late L. Grossman
(Johns Hopkins University, Baltimore, MD) and K.H. Kraemer (NCI,
Bethesda, MD). At least triplicate experiments were performed.
Genomic XPG DNA sequencing
Genomic DNA was isolated using a QIAamp DNA Blood Mini Kit
(Qiagen, Hilden, Germany). Primer pairs for amplification of the
entire coding region and all exon/intron boundaries are listed in
Supplementary Table S1 online. DNA sequencing was performed
using a BigDyeTerminator v3.1 Cycle Sequencing Kit (Applied
Biosystems, Foster City, CA) and analyzed with a 3100-Avant Genetic
Analyzer (Applied Biosystems) and Chromas Lite version 2.01 soft-
ware (Technelysium Pty, Brisbane, Australia).
XPG mRNA expression analysis
Total RNA was isolated using an RNeasy Mini Kit and an RNase-free
DNase Set (Qiagen). cDNA was generated using a RevertAid H Minus
First strand cDNA synthesis Kit (MBI Fermentas, St Leon-Rot,
Germany). Expression levels of XPG cDNA were determined by
quantitative real-time PCR using a QuantiTect SYBR Green Kit
(Qiagen). The expression of GAPDH and b-actin mRNA was
measured as reference. All primers were purchased from Qiagen
(QuantiTect Primer Assays; Cat. No.: QT00029246, QT00079247,
and QT00095431, respectively). Standards were generated by spec-
trophotometric quantification of specific PCR products, and dilution
series ranging from 500 to 0.0005 amoles were used in each run. The
XPG mRNA levels were normalized to the levels of both reference
genes (b-actin and GAPDH). For calculation of the XPG mRNA
expression of the three patients, the mean XPG mRNA expression
level of nine wild-type fibroblasts was set to 100%.
Generation of pXPGmut and myc-tagged XPGwtmycHis and
XPGmutmycHis constructs
To test the repair function of the XPG mutations, site-directed
mutagenesis was applied to pXPG (primer sequences summarized
in Supplementary Table S2 online), and HCR was performed as
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Figure 5. The XPG protein. (a) Scheme of the wild-type XPG protein with N-region (1–95) and I-region (766–873) corresponding to the endonuclease function,
as well as C-terminal nuclear localization signals (NLS). The spacer region is located between the N-region and I-region, and spans about 600 amino acids.
The five XPG-protein alterations are depicted. XPB and XPD interaction sites (1–377 and 747–928) are underlined. (b) Alignment of a stretch of the I-region
(human amino acids 773–818) over different species (human, mouse, and chicken) revealed the three amino-acid residues L778, G805, and W814 to be
highly conserved. Affected amino acids are framed. Underlined amino acids differ between the species.
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described (Emmert et al., 2002). Wild-type XPG cDNA was amplified
from pXPG plasmid with forward primer 50-AATGCGGCCGCTTA
GAGTAGAAGTTGTCG-30 and reverse primer 50-ATTGGTACCGGTT
TTCCTTTTTCTTCC-30, each carrying a NotI or KpnI restriction site,
respectively, and subcloned into pcDNA3.1/myc-His( )A. For
generation of the two truncated proteins, XPG1–150mycHis and
XPG1–727mycHis, the forward primer 5
0-AATGCGGCCGCTT
AGAGTAGAAGTTGTCG-30 was used together with the reverse
primers 50-ATTGGTACCTTGTAAAGGAGGCAAAAC-30 and 50-
ATTGGTACCTTCATGGAGCGAATCTTCCGC-30, respectively. For
the XPGmutmycHis constructs carrying one of the three missense
mutations, XPGwtmycHis was used as a template for site-directed
mutagenesis as described above (Supplementary Table S2 online).
Immunoprecipitation
For immunoprecipitation of the mycHis-tagged XPG proteins,
HEK293A cells were used. Twenty-four hours after transfection, cells
were trypsinized and diluted in 1 ml of IP Lysis Buffer (50 mM
Tris–HCl (pH 7.6 at 4 1C), 150 mM NaCl, 1 mM DTT, and 1 mM EDTA)
containing 1 mM phenylmethylsulfonyl fluoride and protease inhibitor
(Complete ULTRA Tablets Mini EDTA free EASYpack; Roche, Man-
nheim, Germany). Precipitation of XPGmycHis protein was performed
by adding an anti-myc mouse antibody at a dilution of 1:1,000 (Cell
Signaling, Danvers, MA). Control IP was performed using a mouse
IgG antibody (Dako, Glostrup, Denmark). A volume of 50ml of a 1:1
mixture of AgaroseA beads and AgaroseGþ (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) was added to each sample and washed five
times with IP Lysis Buffer.
Horizontal SDS-PAGE and western blotting
For SDS-PAGE, the Amersham ECL electrophoresis system with a
precast 4–12% polyacrylamide gradient gel (Amersham, GE Health-
care Biosciences, Piscataway, NJ) was used applying the wet-blot
method in a XCellII Blot Module (Invitrogen). As blocking buffer for
anti-myc and anti-cdk7 mouse antibodies (myc 9B11 and cdk7 MOI;
Cell Signaling Technology), Tris-buffered saline (20 mM Tris-HCl, pH
7.5, and 150 mM NaCl) containing 0.1% Tween and 5% milk powder
(Merck, Darmstadt, Germany) was used. Blocking buffer for the anti-
XPD rabbit antibody (H-150; Santa Cruz Biotechnology) was obtained
from the WesternBreeze Chemiluminescent Immunodetection System
(Invitrogen). Incubation with the specific antibodies was performed
over night at 4 1C (anti-myc ab 1:1,000, anti-cdk7 ab 1:1,000, and
anti-XPD ab 1:100). Finally, incubation with the secondary antibodies
(anti-mouse or anti-rabbit) and chemiluminescent substrates was
performed using the WesternBreeze Chemiluminescent Immunode-
tection Systems and analyzed using the luminescent image analyzer
LAS-4000 (Fujifilm, Du¨sseldorf, Deutschland).
Immunofluorescence XP protein recruitment kinetics
Fibroblast cells (2 104 per well) were seeded on glass coverslips in
24-well plates (Greiner Bio-One, Frickenhausen, Germany) and
irradiated with 100 J m 2 UVC (UVC 500 UV Crosslinker; Amer-
shamBiosciences, Freiburg, Germany) through a 5-mm Isopore poly-
carbonate filter membrane (Neuro Probe Inc., Gaithersburg, MD). At
different time points (6 minuntes, 15 minuntes, 30 minuntes, 3 hours,
6 hours, and 24 hours), cells were fixed with 3.7% formaldehyde and
permeabilized with 0.1% Triton-X-100 (Merck). Antibodies against
one of the XP proteins (XPA, FL-273; XPB, S-19; XPC, H-300; ERCC1,
FL-297; and XPG, 8H7; Santa Cruz Biotechnology) were added
(1:50), followed by incubation with a secondary anti-rabbit antibody
conjugated with DyLight488 (1:400) (Dianova, Hamburg, Germany).
For detection of photolesions, DNA was denatured with 2 M HCl
before addition of CPD (1:1,000) or with 6,4PP antibodies (1:500;
30 minutes at 37 1C), followed by incubation with a secondary anti-
mouse antibody conjugated with Dylight594 for 1 hours at 37 1C
(1:500) (Dianova). Cells were mounted with the Vectashield Mount-
ing Medium for 4’,6-diamidino-2-phenylindole fluorecsence (Vector
Laboratories, Inc., Burlingame, Canada), and digital images were
taken with an Axio Imager.M1 microscope (Carl Zeiss, Oberkochen,
Germany). At least 100 nuclei were evaluated for the calculation of
percentage of positive staining.
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